Lipomedix Pharmaceuticals Inc.
4 clinical trials · Sponsor
◉ Watch Lipomedix Pharmaceuticals Inc.
| Record | Firm | Date |
|---|---|---|
| Promitil Treatment of Patients With Solid Tumors Associated With Deleterious Mutations Who Have Progressed After Therapy (NCT06478862) | Lipomedix Pharmaceuticals Inc. | 2024-06-13 |
| Assessment of Safety and Therapeutic Efficacy of Promitil in Combination With Folfox in Patients With GI Malignancies (NCT04729205) | Lipomedix Pharmaceuticals Inc. | 2021-01-13 |
| Intravenously Administered Liposomal PROMITIL in Combination With External Beam Radiotherapy in Cancer Patients (NCT03823989) | Lipomedix Pharmaceuticals Inc. | 2019-01-03 |
Track Lipomedix Pharmaceuticals Inc. automatically
Every clearance here is in the API, with alerts when new ones post.